| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 7 |
| GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A0A3S7WXI2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.633 |
| CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.517 |
| CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.679 |
| CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.560 |
| CLV_PCSK_FUR_1 | 22 | 26 | PF00082 | 0.623 |
| CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.607 |
| CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.360 |
| CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.495 |
| CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.702 |
| CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.567 |
| CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.360 |
| CLV_PCSK_PC7_1 | 6 | 12 | PF00082 | 0.592 |
| CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.463 |
| DEG_APCC_DBOX_1 | 11 | 19 | PF00400 | 0.304 |
| DOC_MAPK_gen_1 | 10 | 17 | PF00069 | 0.420 |
| DOC_MAPK_MEF2A_6 | 10 | 17 | PF00069 | 0.420 |
| DOC_MAPK_NFAT4_5 | 10 | 18 | PF00069 | 0.421 |
| DOC_PP1_RVXF_1 | 73 | 80 | PF00149 | 0.284 |
| LIG_14-3-3_CanoR_1 | 6 | 10 | PF00244 | 0.408 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.401 |
| LIG_EH1_1 | 45 | 53 | PF00400 | 0.327 |
| LIG_FHA_1 | 26 | 32 | PF00498 | 0.502 |
| LIG_FHA_1 | 89 | 95 | PF00498 | 0.315 |
| LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.414 |
| LIG_LIR_Gen_1 | 80 | 89 | PF02991 | 0.348 |
| LIG_LIR_Nem_3 | 80 | 84 | PF02991 | 0.348 |
| LIG_Pex14_2 | 88 | 92 | PF04695 | 0.388 |
| LIG_SH2_STAP1 | 139 | 143 | PF00017 | 0.509 |
| LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.474 |
| LIG_SH3_3 | 79 | 85 | PF00018 | 0.294 |
| LIG_TRAF2_1 | 111 | 114 | PF00917 | 0.592 |
| LIG_UBA3_1 | 69 | 75 | PF00899 | 0.356 |
| LIG_WRC_WIRS_1 | 89 | 94 | PF05994 | 0.315 |
| MOD_CK2_1 | 177 | 183 | PF00069 | 0.768 |
| MOD_GlcNHglycan | 54 | 57 | PF01048 | 0.629 |
| MOD_N-GLC_1 | 25 | 30 | PF02516 | 0.681 |
| MOD_NEK2_1 | 17 | 22 | PF00069 | 0.469 |
| MOD_NEK2_1 | 52 | 57 | PF00069 | 0.451 |
| MOD_NEK2_1 | 77 | 82 | PF00069 | 0.459 |
| MOD_NEK2_1 | 88 | 93 | PF00069 | 0.327 |
| MOD_PKA_2 | 5 | 11 | PF00069 | 0.397 |
| MOD_Plk_4 | 142 | 148 | PF00069 | 0.624 |
| MOD_Plk_4 | 88 | 94 | PF00069 | 0.315 |
| TRG_DiLeu_BaEn_1 | 142 | 147 | PF01217 | 0.529 |
| TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.421 |
| TRG_ER_diArg_1 | 154 | 156 | PF00400 | 0.717 |
| TRG_ER_diArg_1 | 24 | 27 | PF00400 | 0.458 |
| TRG_ER_diArg_1 | 9 | 12 | PF00400 | 0.405 |
| TRG_Pf-PMV_PEXEL_1 | 126 | 130 | PF00026 | 0.301 |
| TRG_Pf-PMV_PEXEL_1 | 148 | 152 | PF00026 | 0.457 |
| TRG_Pf-PMV_PEXEL_1 | 173 | 177 | PF00026 | 0.360 |
| TRG_PTS2 | 1 | 35 | PF00400 | 0.417 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P2Y2 | Leptomonas seymouri | 46% | 100% |
| A0A0S4JFQ3 | Bodo saltans | 33% | 100% |
| A4HCN8 | Leishmania braziliensis | 65% | 100% |
| A4I063 | Leishmania infantum | 98% | 100% |
| E9AW26 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
| Q4QBF1 | Leishmania major | 89% | 100% |